ABSI
Absci Corp
$10.60
-0.87 (-7.59%)
At close · Jul 10
Market Cap
$1.65B
Shares
155,905,056
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.60
Open$11.37
Day$10.32–11.41
52W$2.24–12.06
Avg vol 30d7.3M
Short int36.9M · 23.7% float · 3.4d
Short vol56%
Last earningsMay 7, 2026
DataJul 2021–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+148%
above
Price vs 50-day avg
+46%
above
RSI (14)
61
neutral
MACD trend
Negative
52-week position
85%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+66%
trailing
6-month return
+248%
trailing
YTD return
+204%
this year
Relative strength
+238%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
4 of 164 funds reported for Jun 30 · net +81.6K sh shares · +1 new
Insider flow
Accumulating
Net +$349.6K over 90 days · 0% sells
Short interest
Rising
23.69% of float · ▲ +10.7% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
164 holders — near 3-yr high, broad support
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
−21%
Y/Y
EPS growth
+11%
Y/Y
Free cash flow
$-94.0M
Balance sheet
$16.0M
net cash
Quant / Vol
risk profile
Volatility
105%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
9.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+148%
Bullish
Price vs 50-day avg
+46%
Bullish
RSI (14)
61
Neutral
MACD trend
Negative
Bearish
52-week position
85%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $7 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
4 of 164 funds reported for Jun 30 · net +81.6K sh shares · +1 new
Insider flow
Accumulating
Net +$349.6K over 90 days · 0% sells
Short interest
Rising
23.69% of float · ▲ +10.7% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
164 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $11 · 85%
52-wk high $12
vs 200-day avg +148%
vs 50-day avg +46%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABSI
this stock
Absci Corp
|
$1.65B | +203.7% | -20.7% | — | 23.7% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABSI | -8.8% | +66.1% | +247.5% | -8.5% | +203.7% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -10.2% | +62.1% | +238.5% | -9.6% | +193.0% |